We are live on ! Find out more
APM

Avidity Partners Management Portfolio holdings

AUM $936M
1-Year Est. Return 195%
This Fund
S&P 500
This Quarter Est. Return
+7.15%
1 Year Est. Return
+195%
3 Year Est. Return
+460.87%
5 Year Est. Return
+815.5%
10 Year Est. Return
–
AUM
$3.62B
AUM Growth
+$540M
Cap. Flow
+$569M
Cap. Flow %
15.72%
Top 10 Hldgs %
34.44%
Holding
132
New
36
Increased
34
Reduced
15
Closed
38

Top Buys

Rank Stock Value
1
ISRG icon
Intuitive Surgical
ISRG
+$105M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$93.1M
3
MDT icon
Medtronic
MDT
+$84.8M
4
NUVB icon
Nuvation Bio
NUVB
+$84.1M
5
ABBV icon
AbbVie
ABBV
+$77.1M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$137M
2
DGX icon
Quest Diagnostics
DGX
+$94.4M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$87.1M
4
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$57.5M
5
ORGO icon
Organogenesis Holdings
ORGO
+$55M

Sector Composition

Rank Sector Weight
1 Healthcare 95.31%
2 Financials 0.29%
3 Industrials 0%
4 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EVLO
76
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$8.56M 0.24%
+40,000
New +$11.1M
WGS icon
77
GeneDx Holdings
WGS
$1.93B
$8.19M 0.23%
+16,667
New +$8.67M
VSPRU
78
DELISTED
Vesper Healthcare Acquisition Corp. Unit
VSPRU
$6.93M 0.19%
600,000
– –
NAUT icon
79
Nautilus Biotechnolgy
NAUT
$141M
$6.89M 0.19%
500,000
– –
ARGX icon
80
argenx
ARGX
$55.2B
$5.51M 0.15%
+20,000
New +$6.32M
BLSA
81
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$5.29M 0.15%
500,000
– –
ARYD
82
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$5.24M 0.14%
+500,000
New +$5.4M
MSACU
83
DELISTED
Medicus Sciences Acquisition Corp. Unit
MSACU
$5.12M 0.14%
+520,000
New +$5.29M
HCAQ
84
DELISTED
HealthCor Catalio Acquisition Corp. Class A Ordinary Shares
HCAQ
$5M 0.14%
+500,000
New +$5.12M
OBIO icon
85
Orchestra BioMed
OBIO
$232M
$4.48M 0.12%
400,000
– –
CMIIU
86
DELISTED
CM Life Sciences II Inc. Unit
CMIIU
$4.31M 0.12%
+336,700
New +$4.23M
MLTX icon
87
MoonLake Immunotherapeutics
MLTX
$1.58B
$4.08M 0.11%
400,000
– –
SNCE
88
DELISTED
Science 37 Holdings, Inc. Common Stock
SNCE
$4.06M 0.11%
20,000
– –
COGT icon
89
Cogent Biosciences
COGT
$6.68B
$3.67M 0.1%
417,710
-101,935
-20% -$981K
TNGX icon
90
Tango Therapeutics
TNGX
$4.19B
$3.34M 0.09%
300,000
– –
EYPT icon
91
EyePoint Inc
EYPT
$994M
$2.36M 0.07%
+232,504
New +$2.62M
ANNX icon
92
Annexon
ANNX
$786M
$1.95M 0.05%
70,000
– –
AMWL icon
93
American Well
AMWL
$183M
$1.22M 0.03%
3,513
+1,013
+41% +$549K
NUVB.WS
94
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
$267K 0.01%
+99,999
New +$289K
ACAD icon
95
Acadia Pharmaceuticals
ACAD
$4.44B
– –
-527,600
Closed -$28.2M
ANIK icon
96
Anika Therapeutics
ANIK
$224M
– –
-731,000
Closed -$33.1M
APLS
97
DELISTED
Apellis Pharmaceuticals
APLS
– –
-774,000
Closed -$44.3M
ATRC icon
98
AtriCure
ATRC
$2.02B
– –
-446,600
Closed -$24.9M
BCAB icon
99
BioAtla
BCAB
$5.51M
– –
-1,000
Closed -$1.7M
BIIB icon
100
CALL
Biogen
BIIB
$31.5B
– –
-248,100
Closed -$60.7M
2 3
4
5 6

Similar funds

NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
PWAM
Private Wealth Asset Management Cedar Rapids, Iowa $935M AUM 17.66% 1-Year Est. Return
LJAC
L.J. Altfest & Co New York $935M AUM 27.19% 1-Year Est. Return
NI
NetEase Inc Hangzhou, China $934M AUM 11.31% 1-Year Est. Return
MCM
Massar Capital Management Stamford, Connecticut $934M AUM 14.18% 1-Year Est. Return
TS
Tamar Securities Woodland Hills, California $934M AUM 26.74% 1-Year Est. Return
TW
TritonPoint Wealth Chevy Chase, Maryland $934M AUM 23.95% 1-Year Est. Return
PGA
Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

Avidity Partners Management's Q1 2021 Portfolio in Review

As of Q1 2021, Avidity Partners Management held 132 positions worth $3.62B, up 18% from $3.08B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Avidity Partners Management deployed $569M of net new capital in Q1 2021, opening 36 new positions and adding to 34 existing holdings. Its largest new stake was Intuitive Surgical: 418,200 shares worth $103M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 91% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was Organogenesis Holdings, an estimated $55M trimmed.

  • Avidity Partners Management's largest Q1 2021 buy was Intuitive Surgical: 418,200 shares worth $103M.
  • Avidity Partners Management added most to Medtronic in Q1 2021, an estimated $84.8M increase.
  • Avidity Partners Management's biggest Q1 2021 reduction was Organogenesis Holdings, cutting an estimated $55M.
  • Avidity Partners Management fully exited Eli Lilly in Q1 2021, selling an estimated $137M.
  • Avidity Partners Management's ten largest holdings make up 34% of its $3.62B portfolio in Q1 2021.
  • Avidity Partners Management opened 36 new positions and closed 38 in Q1 2021.
  • Avidity Partners Management's portfolio value rose 18% quarter-over-quarter to $3.62B.

Based on Avidity Partners Management's 13F filing for Q1 2021, filed 17 May 2021.